Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 42 Leukemia, Myeloid, Acute 21 Recurrence 19 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 8 Neoplasms, Plasma Cell 5 Lymphoma 5 Glioblastoma 5 Neurofibrosarcoma 4 Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Non-Hodgkin 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Melanoma 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2 Primary Myelofibrosis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2

Interventions

Paclitaxel 14 Gemcitabine 11 atezolizumab 9 Carboplatin 9 pembrolizumab 8 Docetaxel 8 Irinotecan 7 Bevacizumab 7 Cetuximab 6 Sunitinib 5 Leucovorin 5 Injections 5 Fluorouracil 5 Cyclophosphamide 5 Capecitabine 5 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 temsirolimus 3 spartalizumab 3 pazopanib 3 lenvatinib 3 fludarabine 3 Cisplatin 3 zolbetuximab 2 tocilizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02078349 2020-09-10

Phase I Study of KPT330 in Asian Patients

National University Hospital, Singapore

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡